Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

@inproceedings{Bastard2018OutcomesOH,
  title={Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study},
  author={Mathieu Bastard and Elisabeth S{\'a}nchez-Padilla and Philipp A. du Cros and Atadjan Karimovich Khamraev and Nargiza Parpieva and Mirzagaleg Tillyashaykov and Armen Hayrapetyan and Kamene Kimenye and Shazina Khurkhumal and Themba Dlamini and Santiago P{\'e}rez and A. S. Telnov and Cathy Hewison and Francis F V Varaine and Maryline Bonnet},
  booktitle={PloS one},
  year={2018}
}
BACKGROUND The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance. METHODS We retrospectively reported and compared the DR-TB treatment outcomes of HIV-positive and HIV-negative patients treated with an… CONTINUE READING
3
Twitter Mentions

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES

Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis.

  • The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2015

Similar Papers

Loading similar papers…